PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical Investigation
 
J Clin Invest. 1984 December; 74(6): 1948–1960.
PMCID: PMC425381

Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Abstract

One of the fundamental immunologic characteristics of systemic lupus erythematosus (SLE) is a depressed T cell proliferative response to various specific and nonspecific stimuli. Both intrinsic cellular defect(s) and inhibitory influences of humoral factors, e.g., antilymphocyte autoantibodies or immune complexes, have been postulated to underly this functional abnormality. Because patient serum can induce SLE-like T cell dysfunction in normal cells, an extrinsic mechanism is probably responsible, but the nature and site of action of this humoral activity has not been defined. This laboratory recently described a novel antibody specific for activated T cells in SLE, which raised the possibility that suppression of T cell proliferation by SLE serum involved antibodies directed to surface determinants expressed during the process of activation. In experiments to examine this concept further, relatively warm-reactive antibodies to T cell blasts were found to inhibit strongly the well-characterized T cell response to tetanus toxoid. These antibodies were distinct from conventional cold-reactive IgM antibodies to resting T cells, which exhibited little inhibitory activity. Inhibition involved noncytotoxic effects on early activation events at the level of the responding T cell, which markedly reduced the expression of receptors for interleukin 2. Inhibitory effects on antigen-pulsed macrophages or on T cells already committed to proliferate were not demonstrable. Anti-T blast antibodies were characteristic of active SLE and were detected only occasionally in patients with inactive disease or non-SLE rheumatic disorders. Although the exact antigenic specificity was not identified, considerable evidence was obtained against the presence of antibodies to Ia and certain other surface determinants of functional relevance. Our observations concerning the suppressive effects of anti-T blast antibodies in SLE serum on the T cell response to tetanus toxoid should provide new insight into mechanisms of in vivo T cell dysfunction in this and other immunologic disorders.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Rosenthal CJ, Franklin EC. Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum. 1975 May-Jun;18(3):207–217. [PubMed]
  • Gottlieb AB, Lahita RG, Chiorazzi N, Kunkel HG. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest. 1979 May;63(5):885–892. [PMC free article] [PubMed]
  • Sakane T, Steinberg AD, Green I. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3464–3468. [PubMed]
  • Horwitz DA, Garrett MA, Craig AH. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol. 1977 Jan;27(1):100–110. [PubMed]
  • Karsh J, Dorval G, Osterland CK. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol. 1981 Jun;19(3):437–446. [PubMed]
  • Silverman SL, Cathcart ES. Natural killing in systemic lupus erythematosus: inhibitory effects of serum. Clin Immunol Immunopathol. 1980 Oct;17(2):219–226. [PubMed]
  • Scheinberg MA, Cathcart ES. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus. Clin Exp Immunol. 1976 May;24(2):317–322. [PubMed]
  • Schneider J, Chin W, Friou GJ, Cooper SM, Harding B, Hill RL, Quismorio FP. Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol. 1975 May;20(2):187–192. [PubMed]
  • Tsokos GC, Balow JE. Cytotoxic responses to alloantigens in systemic lupus erythematosus. J Clin Immunol. 1981 Oct;1(4):208–216. [PubMed]
  • Bresnihan B, Jasin HE. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. [PMC free article] [PubMed]
  • Fauci AS, Steinberg AD, Haynes BF, Whalen G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978 Oct;121(4):1473–1479. [PubMed]
  • Sakane T, Steinberg AD, Green I. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum. 1978 Jul-Aug;21(6):657–664. [PubMed]
  • Sakane T, Kotani H, Takada S, Murakawa Y, Ueda Y. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. J Immunol. 1983 Aug;131(2):753–761. [PubMed]
  • Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest. 1984 Mar;73(3):689–700. [PMC free article] [PubMed]
  • Jasin HE, Ziff M. Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum. 1975 May-Jun;18(3):219–228. [PubMed]
  • Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, Reeves JP. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum. 1977 Apr;20(3):829–833. [PubMed]
  • Ginsburg WW, Finkelman FD, Lipsky PE. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol. 1979 Jan;35(1):76–88. [PubMed]
  • Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med. 1980 Jan 1;151(1):91–100. [PMC free article] [PubMed]
  • Cohen PL, Litvin DA, Winfield JB. Association between endogenously activated T cells and immunoglobulin-secreting B cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 1982 Feb;25(2):168–173. [PubMed]
  • Wernet P, Kunkel HG. Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med. 1973 Oct 1;138(4):1021–1026. [PMC free article] [PubMed]
  • Sakane T, Steinberg AD, Reeves JP, Green I. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest. 1979 May;63(5):954–965. [PMC free article] [PubMed]
  • Sagawa A, Abdou NI. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest. 1979 Mar;63(3):536–539. [PMC free article] [PubMed]
  • Glinski W, Gershwin ME, Steinberg AD. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest. 1976 Mar;57(3):604–614. [PMC free article] [PubMed]
  • Sakane T, Steinberg AD, Reeves JP, Green I. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest. 1979 Nov;64(5):1260–1269. [PMC free article] [PubMed]
  • Horwitz DA, Cousar JB. A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med. 1975 Jun;58(6):829–835. [PubMed]
  • Winfield JB, Winchester RJ, Wernet P, Fu SM, Kunkel HG. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum. 1975 Jan-Feb;18(1):1–8. [PubMed]
  • Williams RC, Jr, Bankhurst AD, Montaño JD. IgG antilymphocyte antibodies in SLE detected by 125I protein A. Arthritis Rheum. 1976 Nov-Dec;19(6):1261–1270. [PubMed]
  • Okudaira K, Searles RP, Ceuppens JL, Goodwin JS, Williams RC., Jr Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest. 1982 Jan;69(1):17–24. [PMC free article] [PubMed]
  • Litvin DA, Cohen PL, Winfield JB. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products. J Immunol. 1983 Jan;130(1):181–186. [PubMed]
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. [PubMed]
  • Geha RS, Milgrom H, Broff M, Alpert S, Martin S, Yunis EJ. Effect of anti-HLA antisera on macrophage-T-cell interactions. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4038–4041. [PubMed]
  • Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. [PubMed]
  • Nardiello S, Pizzella T, Russo M, Galanti B. Esterase staining of monocytes in suspensions of Ficoll-Paque isolated mononuclear cells. J Immunol Methods. 1982;52(1):111–114. [PubMed]
  • Winfield JB, Winchester RJ, Wernet P, Kunkel HG. Specific concentration of antilymphocyte antibodies in the serum cryoprecipitates of patients with systemic lupus erythematosus. Clin Exp Immunol. 1975 Mar;19(3):399–406. [PubMed]
  • Stocker JW, Garotta G, Hausmann B, Trucco M, Ceppellini R. Separation of human cells bearing HLA-DR antigens using a monoclonal antibody rosetting method. Tissue Antigens. 1979 Mar;13(3):212–222. [PubMed]
  • Goding JW. The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters. J Immunol Methods. 1976;10(1):61–66. [PubMed]
  • Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed]
  • Miyawaki T, Yachie A, Uwadana N, Ohzeki S, Nagaoki T, Taniguchi N. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation. J Immunol. 1982 Dec;129(6):2474–2478. [PubMed]
  • Okudaira K, Searles RP, Goodwin JS, Williams RC., Jr Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response. J Immunol. 1982 Aug;129(2):582–586. [PubMed]
  • Hirschberg H, Hirschberg T, Nousiainen H, Braathen LR, Jaffe E. The effects of corticosteroids on the antigen presenting properties of human monocytes and endothelial cells. Clin Immunol Immunopathol. 1982 Jun;23(3):577–585. [PubMed]
  • Saxon A, Barnett E. Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid. J Clin Invest. 1984 Feb;73(2):342–348. [PMC free article] [PubMed]
  • Searles RP, Messner RP, Hermanson SM. Antilymphocyte antibodies in rheumatoid arthritis: increased reactivity against activated lymphocytes. Clin Immunol Immunopathol. 1981 Aug;20(2):246–254. [PubMed]
  • Winfield JB, Lobo PI, Singer A. Significance of anti-lymphocyte antibodies in systemic lupus erythematosus. Arthritis Rheum. 1978 Jun;21(5 Suppl):S215–S221. [PubMed]
  • DeFreitas EC, Chesnut RW, Grey HM, Chiller JM. Macrophage-dependent activation of antigen-specific T cells requires antigen and a soluble monokine. J Immunol. 1983 Jul;131(1):23–29. [PubMed]
  • Lipkowitz S, Greene WC, Rubin AL, Novogrodsky A, Stenzel KH. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol. 1984 Jan;132(1):31–37. [PubMed]
  • Gunther GR, Wang JL, Edelman GM. The kinetics of cellular commitment during stimulation of lymphocytes by lectins. J Cell Biol. 1974 Aug;62(2):366–377. [PMC free article] [PubMed]
  • Unanue ER, Beller DI, Lu CY, Allen PM. Antigen presentation: comments on its regulation and mechanism. J Immunol. 1984 Jan;132(1):1–5. [PubMed]
  • Qvigstad E, Thorsby E. Class-II HLA restriction of antigen-specific human T-lymphocyte clones. Evidence of restriction elements on both DR and MT molecules. Scand J Immunol. 1983 Oct;18(4):299–306. [PubMed]
  • Lane HC, Whalen G, Fauci AS. Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. J Clin Invest. 1983 Aug;72(2):636–647. [PMC free article] [PubMed]
  • Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens. J Immunol. 1983 Jul;131(1):152–157. [PubMed]
  • Chang TW, Kung PC, Gingras SP, Goldstein G. Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? Proc Natl Acad Sci U S A. 1981 Mar;78(3):1805–1808. [PubMed]
  • Reinherz EL, Hussey RE, Schlossman SF. A monoclonal antibody blocking human T cell function. Eur J Immunol. 1980 Oct;10(10):758–762. [PubMed]
  • Palacios R, Martinez-Maza O. Is the E receptor on human T lymphocytes a "negative signal receptor"? J Immunol. 1982 Dec;129(6):2479–2485. [PubMed]
  • Kumagai S, Steinberg AD, Green I. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest. 1981 Mar;67(3):605–614. [PMC free article] [PubMed]
  • Okudaira K, Searles RP, Tanimoto K, Horiuchi Y, Williams RC., Jr T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus. J Clin Invest. 1982 Apr;69(4):1026–1038. [PMC free article] [PubMed]
  • Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 Jun;130(6):2651–2655. [PubMed]
  • Winfield JB, Winchester RJ, Kunkel HG. Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum. 1975 Nov-Dec;18(6):587–594. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation